Orchid Pharma Limited

Web: orchidpharma.com NSE: ORCHPHARMA BSE: 524372 SECTOR: Healthcare - Pharmaceuticals & Biotechnology | Add Note | View Notes

954 20(2%)

Volume

2L as on 23, Jun

Open

1,727

High

1,814

Low

1,720

935

VWAP

987

52 Week High

1,133

52 Week Low

480

Viand Research Rating

Quality Score

33/100

Growth Score

27/100

Valuation Score

50/100

Momentum Score

45/100

Analyst Recommendations

BUY/SELL

Hold | Buy | Strong Buy

Analyst Price Target

Market Cap (cr)

4,840

No. of Shares

5.99

P/E

69.62

P/B

6.77

Face Value

Div. Yield

Book Value (TTM)

CASH

DEBT

EPS (TTM)

ROE

9.72

ROCE

Profit Growth

Listing Date

02-Nov-20

Promoter Holding

69.84%

FII Holding

0.8%

DII Holding

20.75%

Price Chart

Price Performance

1 Week6%

1 Month40%

3 Months94%

6 Months94%

1 Year94%

YTD94%

Moving Average

5 Day SMA994

10 Day SMA960

20 Day SMA885

30 Day SMA827

50 Day SMA737

61 Day SMA698

80 Day SMA0

200 Day SMA0

PIVOT LEVEL

	Standard	Camarilla	Fibonacci	Woodie's
Resistance 3	1,035	971	1,016	1,033
Resistance 2	1,016	967	998	1,015
Resistance 1	987	962	987	986
Pivot Point	969	958	969	968
Support 1	940	954	950	938
Support 2	921	949	939	920
Support 3	892	945	921	891

Competitors/Peers

#	Symbol	MCAP	LTP	1W	1M	6M	1Y	P/E	Ind PE	Debt/Eq	NP Qtr Rs.Cr.
1	SUNPHARMA	4,56,655	1899	0%	2%	9%	21%	37	57.7	0.07	11509
2	DIVISLAB	2,43,196	9161	2%	8%	44%	51%	69	57.7	0	2568
3	TORNTPHARM	1,84,303	4846	2%	3%	12%	36%	72	57.7	1.79	2138
4	APOLLOHOSP	1,24,834	8650	1%	1%	12%	10%	58	57.7	0.9	2003
5	ZYDUSLIFE	1,12,897	1132	4%	2%	26%	13%	20	57.7	0.46	5124
6	CIPLA	1,11,346	1385	2%	5%	3%	12%	22	57.7	0.02	3862
7	LAURUSLABS	99,634	1844	3%	3%	75%	114%	0	57.7	0.48	890
8	DRREDDY	96,962	1151	2%	2%	11%	8%	20	57.7	0.2	4158
9	MAXHEALTH	96,646	985	1%	10%	8%	14%	0	57.7	0.32	1442
10	LUPIN	96,620	2113	1%	11%	8%	10%	23	57.7	0.29	5355
Load More

Shareholding Pattern (%)

	Jun 2026	Mar 2026	Dec 2025	Sep 2025	Jun 2025	Mar 2025	Dec 2024	Sep 2024	Jun 2024	Mar 2024	Dec 2023	Sep 2023	Jun 2023	Mar 2023	Dec 2022	Sep 2022	Jun 2022	Mar 2022	Dec 2021	Sep 2021
Promoters	(0.01) 69.84%	(0.01) 69.84%	(0.01) 69.84%	(0.01) 69.84%	(0.01) 69.84%	(0.01) 69.84%	(0.01) 69.84%	(0.01) 69.84%	(0.01) 69.84%	(0.01) 69.84%	(-2.61) 69.84%	(0.01) 72.40%	(-17.61) 72.40%	(0.01) 89.96%	(0.01) 89.96%	(0.01) 89.96%	(0.01) 89.96%	(0.01) 90.00%	(0.01) 90.00%	(0.01) 90.00%
FIIs	(-0.11) 0.80%	(-0.31) 0.87%	(-0.41) 1.17%	(0.21) 1.56%	(-1.31) 1.39%	(0.21) 2.69%	(0.61) 2.53%	(0.51) 1.94%	(-0.51) 1.42%	(-2.21) 1.96%	(-3.91) 4.14%	(-0.51) 8.08%	(7.81) 8.58%	(0.01) 0.81%	(-0.51) 0.86%	(-0.11) 1.37%	(-0.11) 1.48%	(-0.21) 1.61%	(0.01) 1.78%	(0.01) 1.79%
DIIs	(0.51) 20.75%	(0.91) 20.24%	(0.31) 19.38%	(-0.41) 19.04%	(-0.71) 19.43%	(1.11) 20.10%	(0.71) 19.00%	(-0.61) 18.30%	(1.21) 18.93%	(3.21) 17.73%	(2.11) 14.51%	(-1.01) 12.46%	(10.91) 13.48%	(-1.31) 2.62%	(1.01) 3.94%	(0.01) 2.98%	(0.01) 2.97%	(-0.41) 2.97%	(0.01) 3.35%	(0.01) 3.35%
Government	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.04%	0.04%	0.04%	0.04%
Public	8.62%	9.04%	9.61%	9.57%	9.34%	7.37%	8.63%	9.94%	9.82%	10.47%	11.52%	7.05%	5.54%	6.60%	5.22%	5.69%	5.55%	5.39%	4.84%	4.83%
No. of Shareholders	33,433	35,118	35,709	38,155	39,827	34,303	34,158	36,363	34,695	36,720	36,931	29,197	29,132	29,523	30,894	32,717	33,679	33,698	33,533	34,798

Quarterly Results

	Jun 2026	Mar 2026	Dec 2025	Sep 2025	Jun 2025	Mar 2025	Dec 2024	Sep 2024	Jun 2024	Mar 2024	Dec 2023	Sep 2023	Jun 2023	Mar 2023	Dec 2022	Sep 2022	Jun 2022	Mar 2022	Dec 2021	Sep 2021	Jun 2021
Sales	304.17	368.33	207.27	193.52	263.19	237.48	217.34	222.7	244.41	217.1	220.59	198.76	182.92	210	160	165.25	131	178	161	128	92
Sales Growth % (YoY)	15.6%	55.1%	-4.6%	-13.1%	7.7%	9.4%	-1.5%	12%	33.6%	3.4%	38.1%	20.3%	39.6%	17.8%	-1%	29.4%	41.9%	49%	57%	17.7%	-22.5%
Sales Growth % (QoQ)	-17.4%	77.7%	7.1%	-26.5%	10.8%	9.3%	-2.4%	-8.9%	12.6%	-1.6%	11%	8.7%	-12.9%	31.2%	-3.2%	26.1%	-26.4%	10.6%	25.8%	39.1%	-
Expenses	290.17	338.17	205.71	194.99	268.84	209.49	190.97	192.36	211.92	188.19	185.21	175.46	160.78	170	146	147.43	119	152	147	116	95
Operating Profit	14	30.16	1.56	-1.47	-5.65	27.99	26.37	30.34	32.49	28.91	35.38	23.3	22.14	40	14	17.82	12	26	14	11	-3
OPM %	4.6	8.19	0.75	-0.76	-2.15	11.79	12.13	13.62	13.29	13.32	16.04	11.72	12.1	19	9	10.78	10	14	9	9	-3
Other Income	1.83	7.55	-1.5	10.77	11.57	3.9	8.49	7.52	7.57	13.36	7.62	8.36	1.89	34	9	5.84	3	0	-1	68	3
Interest	2.23	1.96	3.18	3.73	2.28	3.92	3.8	3.33	3.5	3.47	3.54	3.8	5.55	7	8	9.22	8	4	7	10	11
Depreciation	10.95	10.9	9.03	8.9	10.53	8.87	8.61	8.63	8.44	8.42	9.27	7.84	7.71	7	8	17.76	22	27	20	20	20
Profit before tax	2.65	24.85	-12.15	-3.33	-6.89	19.1	22.45	25.9	28.12	30.38	30.19	20.02	10.77	59	7	-3.32	-14	-5	-14	49	-31
Tax %	2.64	0	0	0	0	-0.21	0	0	-0.53	-10.27	0	0	0	0	0	0	0	0	0	0	0
Net Profit	3.22	25.84	-12.61	-5.72	-5.69	22.29	20.78	27.24	29.35	32.96	29.43	19.8	9.4	59	8	-5.39	-15	-7	-14	49	-31
Net Profit Growth % (QoQ)	-87.5%	304.9%	-120.5%	-0.5%	-125.5%	7.3%	-23.7%	-7.2%	-11%	12%	48.6%	110.6%	-84.1%	637.5%	248.4%	64.1%	-114.3%	50%	-128.6%	258.1%	-
Net Profit Growth % (YoY)	156.6%	15.9%	-160.7%	-121%	-119.4%	-32.4%	-29.4%	37.6%	212.2%	-44.1%	267.9%	467.3%	162.7%	942.9%	157.1%	-111%	51.6%	-	-	-	-
TTM Net Profit	10.73	1.82	-1.73	31.66	64.62	99.66	110.33	118.98	111.54	91.59	117.63	96.2	71.01	46.61	-19.39	-41.39	13	-3	4	18	0
EPS in Rs	0.63	5.09	-2.49	-1.13	-1.12	4.39	4.1	5.37	5.79	6.5	5.8	3.9	1.85	14.49	1.86	-1.32	-3.68	-1.61	-3.4	12.1	-7.57

Profit and Loss

	Mar 2026	Mar 2025	Mar 2024	Mar 2023	Mar 2022	Mar 2021	Mar 2020	Mar 2019	Mar 2018	Mar 2017	Mar 2016	Mar 2015	Sep 2013	Mar 2012	Jan 1900
Sales	1233	922	819	666	560	450	484	600	683	797	873	1747	1948	1874	1747
Sales Growth %	33.7%	12.5%	23%	19%	24.3%	-7%	-19.4%	-12.2%	-14.2%	-8.8%	-50%	-10.3%	4%	5.2%	-
Expenses	1199	804	708	581	505	421	515	612	659	794	703	1429	1837	1517	1429
Operating Profit	34	118	111	84	55	29	-31	-12	24	3	171	317	110	357	317
OPM %	2.7	13	14	13	10	7	-6	-2	3.6	0.4	20	18	6	19	18
Other Income	29	27	31	52	67	15	24	218	20	-59	-28	156	92	52	156
Interest	9	15	17	33	33	52	6	7	310	347	294	537	523	180	537
Depreciation	43	35	33	55	87	109	118	130	133	141	145	325	252	154	325
Profit before tax	10	96	92	48	2	-117	-131	69	-399	-544	-296	-389	-573	75	-389
Tax %	-2	0	-3	0	0	0	0	0	-12	-9	-6	-49	-2	-29	-49
Net Profit	10	100	92	46	-2	-117	-131	69	-353	-495	-279	-197	-560	97	-197
Net Profit Growth %	-90%	8.7%	100%	2400%	98.3%	10.7%	-289.9%	119.5%	28.7%	-77.4%	-41.6%	64.8%	-677.3%	149.2%	-
EPS in Rs	1.96	19.65	18.17	11.35	-0.48	-28.55	-32.11	7.8	-39.65	-55.69	-31.37	-23.06	-79.21	13.84	-23.06
Dividend Payout %	0	0	0	0	0	0	0	0	0	0	0	0	0	22	0

Cash Flows

	Mar 2026	Mar 2025	Mar 2024	Mar 2023	Mar 2022	Mar 2021	Mar 2020	Mar 2019	Mar 2018	Mar 2017	Mar 2016	Mar 2015	Sep 2013	Mar 2012
Cash from Operating Activity	101	19	126	18	92	24	81	12	9	401	212	-369	168	737
Cash from Investing Activity	-285	-27	-312	-31	113	67	167	45	-28	-176	-1	1334	-986	-293
Cash from Financing Activity	170	25	167	31	-217	-165	-250	0	33	-465	-286	-597	664	-480
Net Cash Flow	-14	18	-19	18	-11	-74	-2	57	15	-240	-76	367	-153	-36

Balance Sheet

	Mar 2026	Sep 2025	Mar 2025	Sep 2024	Mar 2024	Mar 2023	Mar 2022	Mar 2021	Mar 2020	Mar 2019	Mar 2018	Mar 2017	Mar 2016	Mar 2015	Sep 2013	Mar 2012
Equity Capital	51	51	51	51	51	41	41	41	41	89	89	89	89	85	70	70
Reserves	1237	1223	1217	1174	1119	648	607	612	725	-793	-881	-556	-40	244	310	1062
Borrowings	363	282	175	165	135	331	268	453	566	3230	3202	3106	3215	3211	3204	2005
Other Liabilities	261	167	246	246	249	205	195	132	128	551	715	616	598	521	1067	801
Total Liabilities	1911	1722	1688	1635	1554	1225	1111	1237	1460	3077	3125	3256	3862	4061	4651	3938
Fixed Assets	692	631	633	650	620	573	584	670	858	1256	1386	1497	1637	1795	2584	2074
CWIP	341	120	81	25	31	46	10	7	26	278	272	288	280	282	360	352
Investments	53	49	50	48	46	44	45	15	0	0	1	1	1	1	1	1
Other Assets	826	922	925	912	857	561	472	544	576	1542	1467	1470	1944	1984	1706	1511
Total Assets	1911	1722	1688	1635	1554	1225	1111	1237	1460	3077	3125	3256	3862	4061	4651	3938

Delivery

Delivery Data: ORCHPHARMA

#	Date	917 24% 1133	Value (Cr)	Q/T 16	Del 41	Del 17
1	4-Sep	955	4	13	46	2
2	3-Sep	935	3	15	56	2
3	2-Sep	938	4	13	56	2
4	1-Sep	948	4	7	51	2
5	31-Aug	971	3	12	54	1
6	28-Aug	976	6	13	47	3
7	27-Aug	929	17	12	48	8
8	26-Aug	973	10	8	55	6
9	25-Aug	1039	6	9	59	4
10	24-Aug	1038	15	11	57	8
11	21-Aug	1002	11	14	72	8
12	20-Aug	980	5	10	57	3
13	19-Aug	980	7	11	43	3
14	18-Aug	969	10	11	49	5
15	17-Aug	998	19	11	40	8
16	14-Aug	1046	7	9	47	3
17	13-Aug	1034	6	10	45	3
18	12-Aug	1063	5	10	49	3
19	11-Aug	1079	21	12	40	8
20	10-Aug	1079	24	14	47	11
21	7-Aug	1002	3	9	44	1
22	6-Aug	998	5	8	46	2
23	5-Aug	990	8	10	38	3
24	4-Aug	1006	2	10	47	1
25	3-Aug	991	4	8	46	2
26	31-Jul	987	3	9	48	1
27	30-Jul	1000	4	9	48	2
28	29-Jul	1001	5	7	37	2
29	28-Jul	985	4	5	47	2
30	27-Jul	988	5	7	42	2
31	24-Jul	989	5	9	36	2
32	23-Jul	962	12	9	47	5
33	22-Jul	1001	10	10	44	4
34	21-Jul	1023	8	8	39	3
35	20-Jul	1047	6	9	28	2
36	17-Jul	1041	13	11	40	5
37	16-Jul	1079	16	14	38	6
38	15-Jul	1101	35	13	30	11
39	14-Jul	1053	83	15	13	11
40	13-Jul	1007	16	14	34	5
41	10-Jul	1013	29	13	32	9
42	9-Jul	1051	77	17	30	23
43	8-Jul	1002	330	26	10	32
44	7-Jul	925	5	10	52	2
45	6-Jul	934	4	13	51	2
46	3-Jul	956	6	14	46	3
47	2-Jul	979	6	14	38	2
48	1-Jul	975	4	13	40	1
49	30-Jun	973	7	16	35	2
50	29-Jun	951	11	20	48	5

Daily Market Cap

Date	Total Market Cap	Change	Chg %
04-Sep	4,840c	69c	1.45
03-Sep	4,771c	138c	2.81
01-Sep	4,909c	15c	0.31
31-Aug	4,894c	177c	3.75
27-Aug	4,717c	482c	9.27
25-Aug	5,199c	71c	1.35
24-Aug	5,270c	294c	5.91
21-Aug	4,976c	2c	0.03
19-Aug	4,977c	58c	1.17
18-Aug	4,920c	150c	2.95
17-Aug	5,069c	226c	4.26
14-Aug	5,295c	132c	2.43
13-Aug	5,427c	25c	0.46
12-Aug	5,403c	234c	4.16
11-Aug	5,637c	134c	2.43
10-Aug	5,503c	446c	8.81
06-Aug	5,058c	17c	0.33
04-Aug	5,041c	15c	0.29
31-Jul	5,026c	36c	0.70
30-Jul	5,062c	2c	0.04
29-Jul	5,064c	33c	0.65
28-Jul	5,031c	10c	0.20
27-Jul	5,021c	46c	0.90
24-Jul	5,067c	0	0

Stock Checklist

Price is above from 52 week high low average: 73%

Stock is trading above all short term SMAs: YES

Stock is trading above all long term SMAs: YES

Stock is Consistently Improving Long Term: NO

FII purchased in last quarter: NO

Promoters are buying the stock: NO

Mutual Fund Holdings

Held by 56 fund scheme(s) across 9 fund house(s) as of Aug26 · Total value ₹2,001 Cr · 36 increasing / 4 decreasing · View in MF Pro →

Fund House	Schemes	Weight %	Change	Value (Cr)
quant Mutual Fund	2	1.01%	+0.29%	683.9
Kotak Mahindra Mutual Fund	16	0.35%	-	462.8
UTI Mutual Fund	8	1.00%	+0.34%	354
Invesco Mutual Fund	6	0.42%	+0.24%	287.4
Bandhan Mutual Fund	14	0.20%	+0.14%	151.2
PGIM India Mutual Fund	4	0.84%	+0.79%	29.4
Tata Mutual Fund	2	1.04%	+0.38%	28.4
WhiteOak Capital Mutual Fund	2	0.31%	+0.02%	4.3
Motilal Oswal Mutual Fund	2	0.00%	+0.01%	0

Orchid Pharma Limited

Price Chart

Price Performance

Moving Average

PIVOT LEVEL

Competitors/Peers

Shareholding Pattern (%)

Quarterly Results

Profit and Loss

Cash Flows

Balance Sheet

Delivery

Daily Market Cap

Stock Checklist

Mutual Fund Holdings

Strategy Builder

Bulk Deals

Events

News

Exchange Filings

Annual Reports

Ratings & Research Reports

Concalls

Announcements